SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-030847
Filing Date
2020-03-10
Accepted
2020-03-09 17:31:39
Documents
7
Period of Report
2020-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012017d1_8k.htm 8-K 65603
2 EXHIBIT 4.1 tm2012017d1_ex4-1.htm EX-4.1 171480
3 EXHIBIT 10.1 tm2012017d1_ex10-1.htm EX-10.1 128596
4 EXHIBIT 99.1 tm2012017d1_ex99-1.htm EX-99.1 19234
5 GRAPHIC tm2012017d1_ex10-1img001.jpg GRAPHIC 13719
6 GRAPHIC tm2012017d1_ex10-1img002.jpg GRAPHIC 13893
7 GRAPHIC tm2012017d1_ex99-1img001.jpg GRAPHIC 13750
  Complete submission text file 0001104659-20-030847.txt   433421
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 20699068
SIC: 2834 Pharmaceutical Preparations